Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

Terry J  Quinn; Phyo K Myint; Jenny  McCleery; Martin  Taylor-Rowan; Carrie Stewart

doi:10.1002/14651858.CD013540

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

Terry J Quinn^* (Corresponding Author)
, Phyo K Myint
, Jenny McCleery
, Martin Taylor-Rowan
, Carrie Stewart

^*Corresponding author for this work

University of Glasgow
Oxford Health NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

14 Downloads (Pure)

Abstract

This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows:

Primary objective: to assess whether ACB in older adults is a prognostic factor for future cognitive decline or dementia.

Secondary objective(s): to assess whether ACB is a prognostic factor for older adults recruited in primary care, secondary care, or community settings (with setting used as the basis for subgroup analyses); whether ACB is associated with mortality; to compare the prognostic validity of respective ACB scales; and to examine the effect of duration of exposure and duration of follow‐up on the ACB‐dementia risk association.

Original language	English
Article number	CD013540
Number of pages	13
Journal	Cochrane Database of Systematic Reviews
Issue number	2
DOIs	https://doi.org/10.1002/14651858.CD013540
Publication status	Published - 18 Feb 2020

Access to Document

10.1002/14651858.CD013540Licence: Unspecified

Quinn_etal_CDSR_Anticholinergic _Burden_VoR
his Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2020, Issue 2. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol.'
Final published version, 167 KBLicence: Other

Cite this

@article{bb3fcbdd456a454cae2a16359c848e6e,

title = "Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome",

abstract = "This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective: to assess whether ACB in older adults is a prognostic factor for future cognitive decline or dementia. Secondary objective(s): to assess whether ACB is a prognostic factor for older adults recruited in primary care, secondary care, or community settings (with setting used as the basis for subgroup analyses); whether ACB is associated with mortality; to compare the prognostic validity of respective ACB scales; and to examine the effect of duration of exposure and duration of follow‐up on the ACB‐dementia risk association.",

author = "Quinn, \{Terry J\} and Myint, \{Phyo K\} and Jenny McCleery and Martin Taylor-Rowan and Carrie Stewart",

year = "2020",

month = feb,

day = "18",

doi = "10.1002/14651858.CD013540",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

AU - Quinn, Terry J

AU - Myint, Phyo K

AU - McCleery, Jenny

AU - Taylor-Rowan, Martin

AU - Stewart, Carrie

PY - 2020/2/18

Y1 - 2020/2/18

N2 - This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective: to assess whether ACB in older adults is a prognostic factor for future cognitive decline or dementia. Secondary objective(s): to assess whether ACB is a prognostic factor for older adults recruited in primary care, secondary care, or community settings (with setting used as the basis for subgroup analyses); whether ACB is associated with mortality; to compare the prognostic validity of respective ACB scales; and to examine the effect of duration of exposure and duration of follow‐up on the ACB‐dementia risk association.

AB - This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective: to assess whether ACB in older adults is a prognostic factor for future cognitive decline or dementia. Secondary objective(s): to assess whether ACB is a prognostic factor for older adults recruited in primary care, secondary care, or community settings (with setting used as the basis for subgroup analyses); whether ACB is associated with mortality; to compare the prognostic validity of respective ACB scales; and to examine the effect of duration of exposure and duration of follow‐up on the ACB‐dementia risk association.

U2 - 10.1002/14651858.CD013540

DO - 10.1002/14651858.CD013540

M3 - Article

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD013540

ER -

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

Abstract

Access to Document

Fingerprint

Cite this